RLBP1 and age-related macular degeneration: Joachim et al. and Adamus et al. also identified promising candidates in AMD patients like anti-enolase aab that even corresponded to different disease stages, or GFAP, Carboxyethylpyrrole, Cellular Retinaldehyde Binding Protein, and Retinol Binding Protein-3 [18,21].